Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
akcea therapeutics
allosteric
anylam pharmaceuticals
atlas venture
atopic dermatitis
autoimmune disorders
biotech
boston
brace pharma
cardiomyopathy
cleva pharma
deals
drug discovery
drugs
dupilumab
glaxosmithkline
hotspot therapeutics
inotersen
investing
jonathan montagu
metabolic diseases
mrl ventures fund
neuropathy
new york
new york blog main
new york top stories
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
sanofi
sofinova parnters
solasta ventures
What
ago
2
×
disease
2
×
medicines
2
×
address
adds
akcea
allosteric
alnylam
amyloidosis
approved
attr
available
battle
clinic
debilitating
drug
elusive
fda
genetic
hotspot
molecules
new
oks
path
patients
pfizer
potential
rare
set
sets
steer
targets
therapeutics
transthyretin
ways
year
years
Language
unset
Current search:
ago
×
medicines
×
disease
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
